| Mylan Pharma GmbH - Influvac, Injektionssuspension | | 00485 | | 28 | | Influvac | | Injektionssuspension | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 02.09.2015 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-181) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Switzerland/9715293/2013 (H3N2)-like: reassortant virus NIB-88) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Phuket/3073/2013) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: ovalbuminum max. 0.1 µg, formaldehydum et cetrimidum et polysorbatum 80 et gentamicinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Injection suspension | | | | | | Active Agent | Dose |
|---|
| Haemagglutininum Influenzae a (H1N1) (Virus-Stamm A/california/7/2009 (H1N1)-Like: Reassortant Virus nymc X-181) | 15 µg | | Haemagglutininum Influenzae a (H3N2) (Virus-Stamm A/switzerland/9715293/2013 (H3N2)-Like: Reassortant Virus Nib-88) | 15 µg | | Haemagglutininum Influenzae b (Virus-Stamm B/phuket/3073/2013) | 15 µg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Calcium Chloride | | | | Cetrimide | | | | Disodium Phosphate Dihydrate | | | | Formaldehydum | | | | Gentamicinum Nihil | | | | Potassium Chloride | | | | Potassium Dihydrogenophosphate | | | | Magnesium Chloride Hexahydrate | | | | Sodium Chloride | | | | Ovalbuminum | 0.1 µg | residui | | Polysorbatum 80 | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
